AKER BIOMARINE ASA (AKBM.OL) Stock Price, Quote, News and Overview
OSL:AKBM - Euronext Oslo - NO0010886625 - Common Stock - Currency: NOK
AKBM.OL Quote, Performance and Key Statistics
OSL:AKBM (5/6/2025, 2:49:11 PM)
52.3
-0.4 (-0.76%)
The current stock price of AKBM.OL is 52.3 NOK. In the past month the price decreased by -5.89%. In the past year, price decreased by -29.73%.
AKBM.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ORK.OL | ORKLA ASA | 18.22 | 117.72B | ||
| MOWI.OL | MOWI ASA | 15.46 | 97.06B | ||
| KTF.DE | MONDELEZ INTERNATIONAL INC-A | 20.88 | 77.34B | ||
| SALM.OL | SALMAR ASA | 22.1 | 65.94B | ||
| BN.PA | DANONE | 20.73 | 51.13B | ||
| BSN.DE | DANONE | 20.73 | 51.13B | ||
| 1KHC.MI | KRAFT HEINZ CO/THE | 9.49 | 30.57B | ||
| KHNZ.DE | KRAFT HEINZ CO/THE | 9.54 | 29.80B | ||
| HSY.DE | HERSHEY CO/THE | 19.83 | 29.72B | ||
| BAKKA.OL | BAKKAFROST P/F | 17.03 | 29.44B | ||
| LSG.OL | LEROY SEAFOOD GROUP ASA | 8.03 | 26.55B | ||
| GRM.DE | GENERAL MILLS INC | 12.26 | 26.53B |
Related stock screener links
About AKBM.OL
Company Profile
Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus and currently employs 249 full-time employees. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Company Info
AKER BIOMARINE ASA
Oksenoyveien 10, P.O. Box 496
Lysaker AKERSHUS NO
Employees: 249
Phone: 4724130000
AKER BIOMARINE ASA / AKBM.OL FAQ
What is the stock price of AKER BIOMARINE ASA today?
The current stock price of AKBM.OL is 52.3 NOK. The price decreased by -0.76% in the last trading session.
What is the ticker symbol for AKER BIOMARINE ASA stock?
The exchange symbol of AKER BIOMARINE ASA is AKBM and it is listed on the Euronext Oslo exchange.
On which exchange is AKBM.OL stock listed?
AKBM.OL stock is listed on the Euronext Oslo exchange.
What is the price forecast or stock price prediction for AKER BIOMARINE ASA stock?
9 analysts have analysed AKBM.OL and the average price target is 79.05 NOK. This implies a price increase of 51.15% is expected in the next year compared to the current price of 52.3. Check the AKER BIOMARINE ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AKER BIOMARINE ASA worth?
AKER BIOMARINE ASA (AKBM.OL) has a market capitalization of 4.59B NOK. This makes AKBM.OL a Mid Cap stock.
How many employees does AKER BIOMARINE ASA have?
AKER BIOMARINE ASA (AKBM.OL) currently has 249 employees.
What are the support and resistance levels for AKER BIOMARINE ASA (AKBM.OL) stock?
AKER BIOMARINE ASA (AKBM.OL) has a support level at 49.97 and a resistance level at 53.81. Check the full technical report for a detailed analysis of AKBM.OL support and resistance levels.
Is AKER BIOMARINE ASA (AKBM.OL) expected to grow?
The Revenue of AKER BIOMARINE ASA (AKBM.OL) is expected to decline by -22.73% in the next year. Check the estimates tab for more information on the AKBM.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AKER BIOMARINE ASA (AKBM.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AKBM.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AKBM.OL, evaluating the profitability, health, valuation and growth aspects
- AKER BIOMARINE ASA (AKBM.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AKER BIOMARINE ASA (AKBM.OL) Sales and EPS estimates to see what analysts future expectations are.
- AKER BIOMARINE ASA (AKBM.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AKER BIOMARINE ASA (AKBM.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- AKER BIOMARINE ASA (AKBM.OL) Stock Chart to make your own analysis
- AKER BIOMARINE ASA (AKBM.OL) Latest news and press-releases to stay up to date.
Does AKER BIOMARINE ASA (AKBM.OL) stock pay dividends?
AKBM.OL does not pay a dividend.
When does AKER BIOMARINE ASA (AKBM.OL) report earnings?
AKER BIOMARINE ASA (AKBM.OL) will report earnings on 2025-07-11.
What is the Price/Earnings (PE) ratio of AKER BIOMARINE ASA (AKBM.OL)?
AKER BIOMARINE ASA (AKBM.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.42).
AKBM.OL Technical Analysis
AKBM.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL. AKBM.OL has an average financial health and profitability rating.
AKBM.OL Financial Highlights
Over the last trailing twelve months AKBM.OL reported a non-GAAP Earnings per Share(EPS) of -0.42. The EPS decreased by -157.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 78.8% | ||
| ROA | 46.54% | ||
| ROE | 103.68% | ||
| Debt/Equity | 0.81 |
AKBM.OL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to AKBM.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 227.5% and a revenue growth -22.73% for AKBM.OL